Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1055/s-0034-1382792 http://scihub22266oqcxt.onion/10.1055/s-0034-1382792 C4139427!4139427!25177085     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Semin+Intervent+Radiol 2014 ; 31 (3): 248-51 Nephropedia Template TP {{tp|p=25177085|t=2014. Outcomes of Transjugular Intrahepatic Portosystemic Shunts for Ascites |pdf=|usr=}}{{25177085}} gab.com Text Outcomes of Transjugular Intrahepatic Portosystemic Shunts for Ascites JO: Semin Intervent Radiol http://www.kidney.de/pget.php?&tw=1&pmid=25177085 #FOAvip Refractory ascites represents a devastating complication of portal hypertension. Transjugular intrahepatic portosystemic shunt (TIPS) is an efficacious option for patients for whom transplant is not an immediate option. Techniques to optimize the hepatic venous pressure gradient and the use of covered stents have reduced rates of hepatic encephalopathy and stent occlusion, respectively. Patients with a Model for End-Stage Liver Disease score less than 15, serum creatinine less than 2 mg/dL, and serum bilirubin less than 2 mg/dL are particularly suited for TIPS placement. TIPS is also effective for hepatic hydrothorax and for massive ascites in the posttransplant setting, although future investigations are necessary to elucidate risk factors and establish the effect on transplant-free survival. Twit Text FOAVip Outcomes of Transjugular Intrahepatic Portosystemic Shunts for Ascites ????Semin Intervent Radiol http://www.kidney.de/pget.php?&tw=1&pmid=25177085 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25177085 #FOAvip English Wikipedia <ref>{{Cite pmid|25177085}}</ref> Outcomes of Transjugular Intrahepatic Portosystemic Shunts for Ascites #MMPMID25177085 Bercu ZL; Fischman AM Semin Intervent Radiol 2014[Sep]; 31 (3): 248-51 PMID25177085show ga Refractory ascites represents a devastating complication of portal hypertension. Transjugular intrahepatic portosystemic shunt (TIPS) is an efficacious option for patients for whom transplant is not an immediate option. Techniques to optimize the hepatic venous pressure gradient and the use of covered stents have reduced rates of hepatic encephalopathy and stent occlusion, respectively. Patients with a Model for End-Stage Liver Disease score less than 15, serum creatinine less than 2 mg/dL, and serum bilirubin less than 2 mg/dL are particularly suited for TIPS placement. TIPS is also effective for hepatic hydrothorax and for massive ascites in the posttransplant setting, although future investigations are necessary to elucidate risk factors and establish the effect on transplant-free survival. äOutcomes of Transjugular Intrahepatic Portosystemic Shunts for Ascites(epmc).pdf DeepDyve Pubget Overpricing